SEC Filings
AngioDynamics' 10-Q Details Honroth CEO Handoff As Cash Falls To $33.97 Million
The 10-Q's subsequent-events note says Honroth succeeds Jim Clemmer on November 2, while cash fell from $53.86 million at May 31.
AngioDynamics (ANGO) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The 10-Q's subsequent-events note says Honroth succeeds Jim Clemmer on November 2, while cash fell from $53.86 million at May 31.
Earnings
The CEO change came with first-quarter revenue of $80.9 million and unchanged full-year guidance, the company said on its earnings call.
SEC Filings
The annual proxy shows bonuses at 180% of target, a board shrinking to seven and a request for more equity-plan room.
Earnings
Med Tech sales rose 13.2% in the fiscal first quarter, and the company reiterated its full-year outlook ahead of a November 2 CEO handover.
SEC Filings
Eric Honroth, a Getinge executive, takes over November 2 from retiring CEO Jim Clemmer, with equity awards and severance terms set in an 8-K.